VRIDAPA MV 10/100/1000 TABLET
Generic Salt Composition: Dapagliflozin 10mg + Metformin 1000mgSR + Vildagliptin 100mgSR
Price: ₹85 MRP: ₹157.5
Save up to 46% compared to branded medicines.
Top Brand Substitutes & Equivalents
Dapagliflozin Metformin Vildagliptin, Vildapride M, Dapa-Vilda-Met, Gluconorm-V, Zomelis-Met, Vildamac-M, Jalra-M, Galvus-Met, Forxiga-Met, Metformin-Dapa-Vilda, Vildagliptin-Dapagliflozin-Metformin, Vildatab-M, Vildapure-M, Vildacare-M, Vildasave-M, Vildafix-M, Vildanex-M, Vildatrio-M, Vildasense-M, Vildatop-M, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500
Product Overview & Uses
VRIDAPA MV 10/100/1000 TABLET is a sophisticated, fixed-dose combination medication falling under the Diabetes Care category, specifically formulated for the management of Type 2 Diabetes Mellitus. The synergy of its three active components—Dapagliflozin, Metformin, and Vildagliptin—allows for a multi-faceted approach to glucose regulation. Dapagliflozin acts by inhibiting the SGLT2 protein in the kidneys, promoting the excretion of glucose via urine. Metformin, the cornerstone of diabetes therapy, improves insulin sensitivity and decreases hepatic glucose production. Vildagliptin, a DPP-4 inhibitor, enhances the body's natural incretin system to stimulate insulin release when blood sugar is high. By utilizing VRIDAPA MV 10/100/1000 TABLET, patients can achieve more stable glycemic control compared to monotherapy. This medication is intended for use alongside a balanced diet and regular physical activity to optimize metabolic health. As a potent therapeutic option, VRIDAPA MV 10/100/1000 TABLET helps in preventing long-term diabetic complications such as neuropathy, retinopathy, and cardiovascular events by maintaining target blood glucose ranges.